FDA Approves Unknown Drug — HIKMA

# FDA Approves Generic Drug Application for Hikma Pharmaceuticals Hikma Pharmaceuticals received FDA approval for ANDA 208809 on July 6, 2017, expanding its generic drug portfolio and positioning the company to capture market share in an additional therapeutic category. The approval strengthens Hikma's competitive standing in the generic pharmaceuticals market and is expected to contribute to revenue growth through increased market penetration.